These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2281807)

  • 1. Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine.
    Nielsen NP; Cesana B; Zizolfi S; Ascalone V; Priore P; Morselli PL
    Acta Psychiatr Scand; 1990 Nov; 82(5):366-71. PubMed ID: 2281807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
    Magni G; Garreau M; Orofiamma B; Palminteri R
    Neuropsychobiology; 1989; 20(3):126-31. PubMed ID: 2668780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 4. Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
    Lloyd KG; Zivkovic B; Sanger D; Depoortere H; Bartholini G
    J Pharmacol Exp Ther; 1987 Apr; 241(1):245-50. PubMed ID: 3033203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
    Gagiano CA; Müller PG; Fourie J; Le Roux JF
    Acta Psychiatr Scand Suppl; 1989; 350():130-1. PubMed ID: 2530765
    [No Abstract]   [Full Text] [Related]  

  • 6. Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression.
    Larsen JK; Gjerris A; Holm P; Anderson J; Bille A; Christensen EM; Høyer E; Jensen H; Mejlhede A; Langagergaard A
    Acta Psychiatr Scand; 1991 Dec; 84(6):564-70. PubMed ID: 1792931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moclobemide and clomipramine in endogenous depression. A randomized clinical trial.
    Koczkas C; Holm P; Karlsson A; Nagy A; Ose E; Pétursson H; Ulverås L; Wenedikter O
    Acta Psychiatr Scand; 1989 Jun; 79(6):523-9. PubMed ID: 2669440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
    Samuelian JC; Hackett D
    J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
    Dick P; Ferrero E
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):419S-425S. PubMed ID: 6407502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.
    Klok CJ; Brouwer GJ; van Praag HM; Doogan D
    Acta Psychiatr Scand; 1981 Jul; 64(1):1-11. PubMed ID: 6172005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.
    Petracca G; Tesón A; Chemerinski E; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):270-5. PubMed ID: 8854297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.
    Noguera R; Altuna R; Alvarez E; Ayuso JL; Casais L; Udina C
    J Affect Disord; 1991 Jul; 22(3):119-24. PubMed ID: 1918655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid liposomes in depression: a double-blind study versus placebo.
    Casacchia M; Meco G; Pirro R; Di Cesare E; Allegro A; Cusimano G; Marola W
    Int Pharmacopsychiatry; 1982; 17(4):274-9. PubMed ID: 7185771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of lofepramine and clomipramine in depressed outpatients.
    Dimitriou E; Paraschos A; Logothetis J
    Psychopharmacol Bull; 1984; 20(4):684-7. PubMed ID: 6387760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.